Medical Device News Magazine

AI Accurately Identifies Normal and Abnormal Chest X-rays

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

An artificial intelligence (AI) tool can accurately identify normal and abnormal chest X-rays in a clinical setting, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA).

Chest X-rays are used to diagnose a wide variety of conditions to do with the heart and lungs. An abnormal chest X-ray can be an indication of a range of conditions, including cancer and chronic lung diseases.

An AI tool that can accurately differentiate between normal and abnormal chest X-rays would greatly alleviate the heavy workload experienced by radiologists globally.

“There is an exponentially growing demand for medical imaging, especially cross-sectional such as CT and MRI,” said study co-author Louis Lind Plesner, M.D., from the Department of Radiology at the Herlev and Gentofte Hospital in Copenhagen, Denmark. “Meanwhile, there is a global shortage of trained radiologists. Artificial intelligence has shown great promise but should always be thoroughly tested before any implementation.”

For this retrospective, multi-center study, Dr. Plesner and colleagues wanted to determine the reliability of using an AI tool that can identify normal and abnormal chest X-rays.

Researchers used a commercially available AI tool to analyze the chest X-rays of 1,529 patients from four hospitals in the capital region of Denmark. Chest X-rays were included from emergency department patients, in-hospital patients and outpatients. The X-rays were classified by the AI tool as either “high-confidence normal” or “not high-confidence normal” as in normal and abnormal, respectively.

Two board-certified thoracic (chest) radiologists were used as the reference standard. A third radiologist was used in cases of disagreements, and all three physicians were blinded to the AI results.

Of the 429 chest X-rays that were classified as normal, 120, or 28%, were also classified by the AI tool as normal. These X-rays, or 7.8 % of all the X-rays, could be potentially safely automated by an AI tool. The AI tool identified abnormal chest X-rays with a 99.1% of sensitivity.

“The most surprising finding was just how sensitive this AI tool was for all kinds of chest disease,” Dr. Plesner said. “In fact, we could not find a single chest X-ray in our database where the algorithm made a major mistake. Furthermore, the AI tool had a sensitivity overall better than the clinical board-certified radiologists.”

According to the researchers, further studies could be directed toward larger prospective implementation of the AI tool where the autonomously reported chest X-rays are still reviewed by radiologists.

The AI tool performed especially well at identifying normal X-rays of the outpatient group at a rate of 11.6%. This suggests that the AI model would perform especially well in outpatient settings with a high prevalence of normal chest X-rays.

“Chest X-rays are one of the most common imaging examination performed worldwide,” Dr. Plesner said. “Even a small percentage of automatization can lead to saved time for radiologists, which they can prioritize on more complex matters.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”